Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 February 2006 to 28 February 2006 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC) Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 February 2006 to 28 February 2006 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC [1] or Article 38 of Directive 2001/82/EC [2]) (2006/C 78/04) — Issuing, maintenance or modification of a national marketing authorisation Date of the decision | Name(s) of the medicinal product | Holder(s) of the marketing authorization | Member State concerned | Date of notification | 21.2.2006 | Lanzoprazol ratiopharm | See Annex I | See Annex I | 23.2.2006 | 21.2.2006 | Lansoprazol ABZ-Pharma | See Annex II | See Annex II | 23.2.2006 | 21.2.2006 | Lansoprazol CT-Arzneimittel | See Annex III | See Annex III | 23.2.2006 | [1] OJ L 311, 28.11.2001, p. 67. [2] OJ L 311, 28.11.2001, p. 1. -------------------------------------------------- ANNEX I LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, APPLICANT, MARKETING AUTHORISATION HOLDER IN THE MEMBER STATES Member State | Marketing Authorisation Holder | Applicant | Invented name | Strength | Pharmaceutical Form | Route of administration | Austria | — | ratiopharm Arzneimittel Vertriebs-GmbH Albert-Schweitzer-G. 3 A-1140 Wien | Lansoprazol %quot%ratiopharm%quot% 15 mg Kapseln | 15 mg | Gastro-resistant capsule, hard | Oral use | Lansoprazol %quot%ratiopharm%quot% 30 mg Kapseln | 30 mg | Gastro-resistant capsule, hard | Oral use | Belgium | — | ratiopharm Belgium Rue Saint-Lambert 14 B-1120 Bruxelles/Brussel | Lansoprazol-ratiopharm 15 mg gelules gastro-résistante | 15 mg | Gastro-resistant capsule, hard | Oral use | Lansoprazol-ratiopharm 30 mg gelules gastro-résistante | 30 mg | Gastro-resistant capsule, hard | Oral use | Denmark | — | ratiopharm GmbH Graf-Arco-Straße 3 D-89079 Ulm | Lantrolix 15 mg enterokapsler, hårde | 15 mg | Gastro-resistant capsule, hard | Oral use | Lantrolix 30 mg enterokapsler, hårde | 30 mg | Gastro-resistant capsule, hard | Oral use | Finland | ratiopharm GmbH Graf-Arco-Straße 3 D-89079 Ulm | — | Lansoprazol ratiopharm 15 mg | 15 mg | Gastro-resistant capsule, hard | Oral use | Lansoprazol ratiopharm 30 mg | 30 mg | Gastro-resistant capsule, hard | Oral use | Germany | — | ratiopharm GmbH Graf-Arco-Straße 3 D-89079 Ulm | Lansoprazol-ratiopharm 15 mg Hartkapseln | 15 mg | Gastro-resistant capsule, hard | Oral use | Lansoprazol-ratiopharm 30 mg Hartkapseln | 30 mg | Gastro-resistant capsule, hard | Oral use | Italy | — | ratiopharm GmbH Graf-Arco-Straße 3 D-89079 Ulm | Lansoprazolo ratiopharm 15 mg capsule di gelatina dura | 15 mg | Gastro-resistant capsule, hard | Oral use | Lansoprazolo ratiopharm 30 mg capsule di gelatina dura | 30 mg | Gastro-resistant capsule, hard | Oral use | Luxembourg | — | ratiopharm GmbH Graf-Arco-Straße 3 D-89079 Ulm | Lansoprazol-ratiopharm 15 mg Hartkapseln | 15 mg | Gastro-resistant capsule, hard | Oral use | Lansoprazol-ratiopharm 30 mg Hartkapseln | 30 mg | Gastro-resistant capsule, hard | Oral use | Portugal | — | ratiopharm Lda, Portugal Edifício Tejo, 6.o piso Rua Quinta do Pinheiro P-2790-143 Carnaxide | Lansoprazol ratiopharm 15 mg cápsulas gastro-resistentes | 15 mg | Gastro-resistant capsule, hard | Oral use | Lansoprazol ratiopharm 30 mg cápsulas gastro-resistentes | 30 mg | Gastro-resistant capsule, hard | Oral use | Sweden | — | ratiopharm GmbH Graf-Arco-Straße 3 D-89079 Ulm | Sopranix 15 mg, enterokapsler, hårda | 15 mg | Gastro-resistant capsule, hard | Oral use | Sopranix 30 mg, enterokapsler, hårda | 30 mg | Gastro-resistant capsule, hard | Oral use | -------------------------------------------------- ANNEX II LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, APPLICANT, MARKETING AUTHORISATION HOLDER IN THE MEMBER STATES Member State | Marketing Authorisation Holder | Applicant | Invented name | Strength | Pharmaceutical Form | Route of administration | Finland | ratiopharm GmbH Graf-Arco-Str. 3 D-89075 Ulm | — | Lansoprazol AbZ-Pharma 15 mg | 15 mg | Gastro-resistant capsule, hard | Oral use | Lansoprazol AbZ-Pharma 30 mg | 30 mg | Gastro-resistant capsule, hard | Oral use | Germany | — | ratiopharm GmbH Graf-Arco-Str. 3 D-89075 Ulm | Lansoprazol AbZ 15 mg Hartkapseln | 15 mg | Gastro-resistant capsule, hard | Oral use | Lansoprazol AbZ 30 mg Hartkapseln | 30 mg | Gastro-resistant capsule, hard | Oral use | -------------------------------------------------- ANNEX III LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, APPLICANT, MARKETING AUTHORISATION HOLDER IN THE MEMBER STATES Member State | Marketing Authorisation Holder | Applicant | Invented name | Strength | Pharmaceutical Form | Route of administration | Finland | ratiopharm GmbH Graf-Arco-Straße 3 D-89079 Ulm | — | Lansoprazol CT-Arzneimittel 15 mg | 15 mg | Gastro-resistant capsule, hard | Oral use | Lansoprazol CT-Arzneimittel 30 mg | 30 mg | Gastro-resistant capsule, hard | Oral use | Germany | — | ratiopharm GmbH Graf-Arco-Straße 3 D-89079 Ulm | Lansoprazol-CT 15 mg Hartkapseln | 15 mg | Gastro-resistant capsule, hard | Oral use | Lansoprazol-CT 30 mg Hartkapseln | 30 mg | Gastro-resistant capsule, hard | Oral use | --------------------------------------------------
